Efficacy test of Trichoben vaccine administered to calves at different intervals between vaccination and re-vaccination

被引:2
|
作者
Rybnikar, A. [1 ]
Oborilova, E. [1 ]
Hedbavny, R. [1 ]
机构
[1] Bioveta AS, Ivanovice Na Hane 68323, Czech Republic
关键词
cattle; post-vaccination immunity; challenge; Trichophyton verrucosum;
D O I
10.2754/avb200877020239
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the study was to test a possible extension of the period between vaccination and re-vaccination with the live Trichoben vaccine (Bioveta, a.s., Czech Republic). The calves (n = 61) were vaccinated intramuscularly. The intervals between vaccination and re-vaccination were 3, 5, 7, 10, 14 or 28 days. Another group of calves (n = 16) was vaccinated once with a double dose of the vaccine. The protective immunity against experimental infection with a virulent Trichophyton verrucosum CCM F-650 strain was investigated in animals one month after the last vaccination and compared with a group of non-vaccinated controls (n = 16). Clinical results were evaluated and compared using balanced two-way-ANOVA. The level of post-vaccination immunity in cattle after re-vaccination was sufficient when the intervals were 5, 7, 10, 14 and 28 days. One-time injection of a double prophylactic dose of the vaccine and a 3-day interval between vaccinations reduced the immunity and vaccine efficacy to an unsatisfactory degree. There were significant differences between the groups of calves vaccinated using an interval longer than 5 days, and the group vaccinated once with a double dose, and the group with a 3-day interval between vaccinations. The level of post-vaccination immunity in cattle after re-vaccination at the commonly used interval of 10 - 14 days was identical with the immunity achieved when the interval was reduced to 5 or 7 days or extended up to 28 days. The extension of the interval between vaccinations to 5 - 28 days is recommended for using the Trichoben vaccine in veterinary practice.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 50 条
  • [21] Re vaccination of children with a history of an allergic reaction to a vaccine after a negative intradermal skin test
    Prinneau, M.
    Des Roches, A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S201 - S201
  • [22] Study on the efficacy of an inactivated Mycoplasma hyopneumoniae vaccine (Stellamune® Mycoplasma) at different times of vaccination
    Radeloff, I
    Heinritzi, K
    [J]. PRAKTISCHE TIERARZT, 1998, 79 (06): : 550 - +
  • [23] Efficacy of Infectious Bursal Disease Vaccine in Broiler Chickens Receiving Different Vaccination Programs
    Sarachai, Chatchai
    Chansiripornchai, Niwat
    Sasipreeyajan, Jiroj
    [J]. THAI JOURNAL OF VETERINARY MEDICINE, 2010, 40 (01): : 9 - 14
  • [24] STREPTOCOCCUS-PNEUMONIAE POLYSACCHARIDE VACCINE - AGE AND DOSE RESPONSES, SAFETY, PERSISTENCE OF ANTIBODY, RE-VACCINATION, AND SIMULTANEOUS ADMINISTRATION OF PNEUMOCOCCAL AND INFLUENZA VACCINES
    HILLEMAN, MR
    CARLSON, AJ
    MCLEAN, AA
    VELLA, PP
    WEIBEL, RE
    WOODHOUR, AF
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1981, 3 : S31 - S42
  • [25] Immunogenicity of varicella-zoster virus vaccine by different routes of administration: Comparable vaccination efficacy of one-fifth dose intradermal vaccination to conventional subcutaneous vaccination
    Nishimura, Yuki Nakamura
    Shinkuma, Satoru
    Miyagawa, Fumi
    Haredy, Ahmad
    Gomi, Yasuyuki
    Yamanishi, Koichi
    Asada, Hideo
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2022, 106 (02) : 86 - 92
  • [26] Efficacy and outcomes of BCG re-vaccination in COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
    Jain, Hritvik
    Odat, Ramez M.
    Hussein, Ayham Mohammad
    Dey, Debankur
    Ahmed, Mushood
    Jain, Jyoti
    Goyal, Aman
    Ratnani, Tanya
    Idrees, Muhammad
    Prajjwal, Priyadarshi
    Passey, Siddhant
    Yadav, Rukesh
    [J]. ANNALS OF MEDICINE AND SURGERY, 2024, 86 (09): : 5439 - 5446
  • [27] Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine
    Nystrom, Jessica
    Cardell, Kristina
    Bjornsdottir, Thora Bjorg
    Fryden, Aril
    Hultgren, Catharina
    Sallberg, Matti
    [J]. VACCINE, 2008, 26 (47) : 5967 - 5972
  • [28] RE-VACCINATION COMPARED TO BOOSTER COVID-19 MRNA VACCINATION SIGNIFICANTLY INCREASES THE SEROLOGICAL RESPONSE IN RITUXIMAB-TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES WITHOUT A PRIMARY DETECTABLE SEROLOGICAL COVID-19 VACCINE RESPONSE
    Ammitzboll, C.
    Thomsen, M. K.
    Hermansen, M. L. F.
    Vils, S. R.
    Andersen, J. B.
    Johannesen, A. D.
    Szabados, F.
    Jorgensen, C. M.
    Larsen, M. C. L.
    Erikstrup, C.
    Hauge, E. M.
    Troldborg, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 373 - 374
  • [29] Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial
    Upton, Caryn M.
    van Wijk, Rob C.
    Mockeliunas, Laurynas
    Simonsson, Ulrika S. H.
    McHarry, Kirsten
    van den Hoogen, Gerben
    Muller, Chantal
    von Delft, Arne
    van der Westhuizen, Helene-Mari
    van Crevel, Reinout
    Walzl, Gerhard
    Baptista, Pedro M.
    Peter, Jonathan
    Diacon, Andreas H.
    [J]. ECLINICALMEDICINE, 2022, 48
  • [30] Protein Energy Malnutrition during Vaccination Has Limited Influence on Vaccine Efficacy but Abolishes Immunity if Administered during Mycobacterium tuberculosis Infection
    Hoang, Truc
    Agger, Else Marie
    Cassidy, Joseph P.
    Christensen, Jan P.
    Andersen, Peter
    [J]. INFECTION AND IMMUNITY, 2015, 83 (05) : 2118 - 2126